Lenzilumab. Anti-GM-CSF monoclonal antibody, Treatment of chronic myelomonocytic leukemia, Treatment of COVID-19
-
Published:2022
Issue:12
Volume:47
Page:887
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Author:
Kalaiger A.M.,Assi M.,Temesgen Z .
Subject
Pharmacology (medical),Pharmacology